PHARMACOPEIA INC
SC 13G, EX-1.1, 2001-01-11
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: PHARMACOPEIA INC, SC 13G, 2001-01-11
Next: PHARMACOPEIA INC, 3, 2001-01-11






                                                                    Exhibit 1.1
                                                                    ----------

                             JOINT FILING AGREEMENT

The undersigned hereby agree that the Statement on Schedule 13G, dated January
11, 2001, (the "Schedule 13G"), with respect to the Common Stock, par value
$0.0001 per share, of Pharmacopeia Inc. is, and any amendments thereto executed
by each of us shall be, filed on behalf of each of us pursuant to and in
accordance with the provisions of Rule 13d-1(k) under the Securities and
Exchange Act of 1934, as amended, and that this Agreement shall be included as
an Exhibit to the Schedule 13G and each such amendment. Each of the undersigned
agrees to be responsible for the timely filing of the Schedule 13G and any
amendments thereto, and for the completeness and accuracy of the information
concerning itself contained therein. This Agreement may be executed in any
number of counterparts, all of which taken together shall constitute one and the
same instrument.

        IN WITNESS WHEREOF, the undersigned have executed this Agreement as of
the 11th day of January, 2001.


                                                         OrbiMed Advisers Inc.

                                                  By: /s/ Samuel D. Isaly
                                                  ----------------------------
                                                  Name:  Samuel D. Isaly
                                                  Title: President

                                                            OrbiMed Advisors LLC

                                                  By: /s/ Samuel D. Isaly
                                                  ----------------------------
                                                  Name:  Samuel D. Isaly
                                                  Title: Managing Member






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission